Kansas City, MO, United States of America

Ritesh Jain

This inventor holds 2 USPTO granted patents. Top assignee: University of Missouri. Active years: 2007-2011.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ritesh Jain. Retrieved from https://idiyas.com/inventor/ritesh-jain-yknucakv

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 50.0

Average Co-Inventor Count = 4.0

ph-index = 2

Forward Citations = 22(Granted Patents)


Company Filing History:


Years Active: 2007-2011

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Inventor Ritesh Jain

Introduction: Ritesh Jain, an inventive force located in Kansas City, MO, has made significant strides in the field of pharmaceutical sciences. With a total of two patents to his name, Jain is at the forefront of developing innovative solutions aimed at improving drug delivery systems and efficacy.

Latest Patents: Jain's most recent patents reflect his expertise in pharmacology. The first patent describes “Peptidyl prodrugs that resist P-glycoprotein mediated drug efflux - A method of treating a patient for a condition wherein the bioactive agent of choice is defined as DRUG. This method emphasizes the administration of an effective amount of a compound represented by a specific formula, which includes various amino acids and stipulations regarding the active ingredient. Notably, DRUG is specified to be neither acyclovir nor ganciclovir and is non-peptidyl.

The second patent, also under the same title, elaborates on the creation of dipeptide, tripeptide, and tetrapeptide ester derivatives of bioactive agents. These derivatives are particularly useful for treating conditions similar to those addressed by the original bioactive agents. Additionally, the patent discusses methods for preparing bioactive agents for targeted delivery using nutrient or peptide transporters, linking the agents to particular formulas for enhanced efficacy.

Career Highlights: Ritesh Jain's career is marked by his affiliation with the University of Missouri, one of the prominent institutions dedicated to research and innovation. His work has been pivotal in advancing methods for drug delivery that have potential implications in various therapeutic areas.

Collaborations: Jain collaborates closely with esteemed colleagues such as Ashim K Mitra and Soumyajit Majumdar. Their joint efforts reflect a commitment to pushing the boundaries of knowledge and improving patient care through innovative drug designs.

Conclusion: Ritesh Jain’s contributions to the field of pharmaceutical sciences through his patents showcase his talent and dedication as an inventor. His innovative approaches to overcoming challenges in drug delivery enhance the landscape of treatment options available to patients. The combined efforts of Jain and his collaborators set a promising future for advancements in medical therapies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…